Binding of Epstein Barr Virus EBNA2 Unifies Multiple Sclerosis Genetic Mechanisms
Demographics (2)
- AGE - Subject age at enrollment (phv00528579.v1.p1)
- SEX - Biological sex (phv00528573.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for Multiple Sclerosis (phv00528577.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00528578.v1.p1)
Other (11)
- ANALYTE_TYPE - Analyte Type (phv00528583.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00528582.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00528572.v1.p1)
- CURRENT_DRUGS - Drugs Currently Being Taken by Subject (phv00528580.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00528585.v1.p1)
- IS_TUMOR - Tumor status (phv00528584.v1.p1)
- SAMPLE_ID - Sample ID (phv00528581.v1.p1)
- SAMPLE_ID - Sample ID (phv00528575.v1.p1)
- SUBJECT_ID - Subject ID (phv00528576.v1.p1)
- SUBJECT_ID - Subject ID (phv00528571.v1.p1)
- SUBJECT_ID - Subject ID (phv00528574.v1.p1)